Target identification specialists at LeadDiscovery, the drug discovery, development and transfer consultants, have recently focused on a series of compounds that fits just this profile.
Human breast cancers have long been known to express somatostatin SSTR2 receptors and indeed this has been exploited by companies looking for improved way . . .   read more >>